Cargando…
HIV-related Hodgkin lymphoma in the era of combination antiretroviral therapy: incidence, outcome, and evolution of CD4+ T cell lymphocytes
Autor principal: | Egger, Matthias |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3002693/ http://dx.doi.org/10.1186/1750-9378-5-S1-A34 |
Ejemplares similares
-
Risk of HIV-associated Hodgkin lymphoma during the first months after initiation of combination antiretroviral therapy
por: Lanoy, E, et al.
Publicado: (2010) -
Elevated serum levels of CXCL13 precede HIV-associated non-Hodgkin’s lymphoma
por: Hussain, Shehnaz K, et al.
Publicado: (2010) -
Hodgkin’s lymphoma characteristics in HIV-infected and uninfected patients at an urban hospital in the late combined antiretroviral era
por: Gunthel, Clifford, et al.
Publicado: (2012) -
Survival among AIDS patients with and without non-Hodgkin's lymphoma, and NHL-HIV-negative patients
por: Cornejo-Juárez, Patricia, et al.
Publicado: (2007) -
Contemporary Management of Hodgkin Lymphoma and Chronic Lymphocytic Leukemia
por: Kurtin, Sandra E., et al.
Publicado: (2018)